Immunolight develops energy conversion technologies to help commercial, life sciences, industrial, and medicine industries create value.

NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications. NanoString's products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection, and in 2013 launched Prosigna®, its first in vitro diagnostic product for prognosis of early stage breast cancer.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator, CK-136, a novel cardiac troponin activator, reldesemtiv, a novel fast skeletal muscle troponin activator, aficamten, a novel cardiac myosin inhibitor, and CK-3772271, a novel cardiac myosin inhibitor. The company was founded by Ronald D. Vale, Lawrence S. B. Goldstein, James H. Sabry, and James A. Spudich in 1997 and is headquartered in South San Francisco, CA.

PerSeptive Biosystems develops instrumentation systems and consumable products for the purification, analysis, and synthesis of biomolecules. It develops and markets instrument-based systems, reagents, software, and contract services to the life science industry and research community. Customers of PerSeptive Biosystems use these tools to analyze nucleic acids (DNA and RNA) and proteins in order to make scientific discoveries, develop new pharmaceuticals, and conduct standardized testing. Founded in 1989, PerSeptive Biosystems is based in Framingham, Massachusetts. Currently, it operates as a subsidiary of Life Technologies Corporation.

Kraft Foods R&D, Inc., a subsidiary of Mondelez International, Inc., is a German company located in Unterhaching that provides food processing services.

Cellectricon is a leading provider of advanced cell-based screening services to accelerate drug discovery. Exploiting their Cellaxess® Elektra platform, their Discovery Services offering is ideal for compound profiling in excitable primary cells and native tissue. Their services help researchers identify phenotypic effects in highly relevant biological models early enough in a project’s lifecycle to add real value to the decision of whether to pursue or eliminate a compound, which translates to considerable cost savings in the drug development business. With their new services-based business model, we are well-enabled to respond to the demands and challenges faced by the drug discovery industry. Their dedicated team of expert neurobiologists and extensive pharmaceutical industry experience, position us well as a preferred partner Over the past year they have collaborated with several large Pharma partners.

VisionGate is dedicated to saving lives through early cancer detection and prevention, utilizing its revolutionary automated 3D cell imaging platform that is capable of generating high-resolution 3D biosignatures from intact cells. It is a clinical-stage oncology pharmaceutical and diagnostics company. Their lead diagnostic product is the LuCED lung test - a non-invasive sputum-based test that detects abnormal cells which indicate lung cancer and bronchial dysplasia. It was founded by Alan Nelson and is based in Phoenix, Arizona.

Siemens Healthcare Diagnostics, Inc. engages in the vitro diagnostics. It provides healthcare professionals in hospital, reference, and physician office laboratories and point-of-care settings with the vital information required to accurately diagnose, treat, and monitor patients. The company is headquartered in Tarrytown, NY.

Tapestry Pharmaceuticals, Inc. develops, manufactures, and markets an anti-cancer pharmaceutical called Paclitaxel. It focuses on the development of proprietary therapies for the treatment of cancer, new products and technologies may involve the examination of individual molecules and classes of compounds. The company was founded in 1991 and is headquartered in Ankeny, IA.

DKFZ Deutsche Krebsforschungszentrum is a German private company that operates as a cancer research center.

The Georgia Tech Research Corp. provides research and technology support services. Its services include accounting and reports, researcher and operational support services. The comapny was founded by Preston S. Arkwright, Fuller E. Callaway, Jr. and Monie A. Ferst on April 13, 1937 and is headquartered in Atlanta, GA.

Spinal Modulation, Inc. provides medical devices research and development services. The company is based in Menlo Park, California. According to the 2002 Health Assessment on the Prevalence of Chronic Pain, severe chronic pain, as defined by the International Association for the Study of Pain, is prevalent in 10 to 13% of the adult population. Limited treatment options exist for these patients and the burden to the healthcare system is unsustainable. The Spinal Modulation AxiumTM Neurostimulator System is a next-generation intraspinal neuromodulation therapy that stimulates the dorsal root ganglion (DRG) to provide a new pain management option. It has shown promising results in managing chronic intractable leg pain, as well as difficult-to-target anatomies such as the back and foot. By stimulating the DRG, therapy can be adjusted to cover either broad or specific areas of pain throughout the torso and legs, while limiting uncomfortable postural effects typically experienced with other spinal cord stimulators.

Hamde (Ningbo) Intelligent Medical Technology Co., Ltd., established on 2019-01-30, Business scope includes medical technology,Biotechnology,network technology,Technology development of computer hardware and software,technical consulting,Technical Services,Technology Promotion,technology transfer:Medical information consultation;Health Information Consultation;Medical device information consultation;Business Management Consulting;Corporate Image Planning;talent agency;Computer hardware and software,Class I medical device,Wholesale of Class II Medical Devices,retail;Self-operated or agent import and export of goods and technologies,Except for goods and technologies that are restricted or prohibited from being imported or exported by the state.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Ostar Stem Cell Co., Ltd., established on 2009-05-20, Business scope includes biological,Research and development of biochemical products;development of biotechnology,application,Promotion and Consulting Services;Technology development of stem cell clinical medicine,technical consulting,Technology transfer and promotion application services;Development of anti-aging technology,transfer,consult;Experimental analysis instrument,sales of chemical reagents;Training Services(Does not include certification,Does not include nationally recognized vocational certificate training). (Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

DAIKIN INDUSTRIES Ltd. engages in the manufacture and sale of air conditioning equipment. It operates through the following segments: Air Conditioner and Refrigerator, Chemicals, and Others. The Air Conditioner and Refrigerator segment deals with the manufacture, distribution, and installation of air conditioning and refrigeration equipment. The Chemicals segment offers fluorocarbon gas, fluororesin, and other chemical products such as semiconductor etching agent, water and oil repellent, surfactant, carbon fluoride, and fluorine oil. The Others segment covers oil machineries, special machineries, and electronic systems. The company was founded by Akira Yamada on October 25, 1924 and is headquartered in Osaka, Japan.

Part of PerkinElmer, Inc. (United States), Perkin Elmer Ltd. is a South Korean company. The firm manufactures pharmaceutical products.

Ningbo Ruizhen Biotechnology Co., Ltd., established on 2018-10-31, Business scope includes biotechnology development services,Biomaterial Testing Services,Biotechnology Consulting Services,Biotechnology Transfer Services,Import and export of self-operated and agent goods and technologies,Except for goods and technologies that are restricted by the state or prohibited from import and export,equipment,Class I medical device,Wholesale of Class II Medical Devices,retail,Chemical Reagents and Auxiliaries(Free of monitored chemicals,Free of Hazardous Chemicals),cosmetic,Daily chemical products(Removal of hazardous chemicals)manufacture,sales and other legal,regulations,Projects that are not prohibited or do not require operating permits and projects that are not included in the negative list of local industrial development in the decision of the State Council.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)